Avantium - Pharmaceutical Research and Development Services

Avantium supplies state of the art R&D technologies and services to the pharmaceutical and drug development industries.

Through a combination of efficient experimentation technology, new research techniques and modern software, Avantium offers a vast range of fast and efficient pharmaceutical R&D services.

Thanks to Avantium's specialised proprietary research systems, the company continues to deliver pharmaceutical products and drug development processes for the global market that are both affordable and effective. Avantium's primary goal is to accelerate and enhance the research and development activities of our drug-manufacturing clients.

Our high throughput technology platforms address a range of pharmaceutical R&D applications, including: process development, catalyst screening and solid state chemistry. Avantium supplies these technology platforms to clients' R&D facilities during contract research projects. This measure enables Avantium to analyse the R&D potential of its proprietary technology platforms in alternative working environments.

CHEMISTRY, CRYSTALLISATION AND POLYMORPHISM PROCESSES

The company remains at the cutting edge of drug development market due to its experience of innovative rational design and high-efficiency solutions for chemistry, crystallisation and polymorphism processes. Our extensive industry knowledge enables us to deliver high quality services throughout the client's entire product life cycle.

Our services and technology platforms are relevant to early stage development, product life cycle management and API process engineering.

We generate new and extend existing intellectual property for our customers' chemical products and production processes.

Superior integration and synergies are achieved between Avantium and our pharmaceutical customers via initial project activities, subsequent cumstomer familiarisation and appreciation of our technologies and, ultimately, the transference of our proprietary technologies to the customers' site.

SMALL MOLECULE DRUG DEVELOPMENT

We provide a range of services and technology platforms for small molecule drug development processes that addresses specific R&D stages, enables product life cycle management and Active Pharmaceutical Ingredient (API) process engineering. Avantium is also well known for its work in the chemical modification of proteins.

The company establishes and extends the intellectual property of clients' pharmaceutical processes and products.

Avantium sets up initial project activities that help to strengthen relationships with new clients. These efforts ensure that clients eventually come to rely on our superior drug development services and equipment. Ultimately, clients often adopt Avantium's working practices and equipment in their own facilities.

See also Pharmaceutical Technology - Avantium - High Throughput Experimentation

See also Chemicals Technology - Avantium - Chemical Research and Development Services